P
Polares Medical
Medical device company with a novel device for treating mitral valve regurgitation
About Polares Medical
Polares Medical is a pioneering medical device company focused on developing a novel solution for treating mitral valve regurgitation, a condition where the heart's mitral valve doesn't close tightly, allowing blood to flow backward in the heart. The company operates in the medical technology sector, specifically targeting cardiovascular health. Polares Medical's primary clients include hospitals, cardiologists, and healthcare providers who specialize in cardiac care.
The company is headquartered in Lausanne, Switzerland, with an additional office in Palo Alto, California, indicating its international reach and ambition. Polares Medical's business model revolves around the research, development, and commercialization of its proprietary medical device. Revenue is generated through the sale of this device to healthcare institutions and practitioners, as well as potential partnerships and licensing agreements with larger medical technology firms.
By addressing a significant unmet need in the treatment of mitral valve regurgitation, Polares Medical aims to improve patient outcomes and reduce the need for invasive surgical procedures. The company's innovative approach and commitment to advancing cardiovascular health position it as a key player in the medical device industry.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- Ecublens, Switzerland
- Employees
- 23
- Open positions
- None listed
- Dealroom signal
- 89.3/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Surgery, Surgical Equipment, Tech for Hospitals and Clinics, DT and LS, science-based, Swiss DT MedTech
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Mar 2026 | $50M | $200M | Undisclosed | ↗ |
| SERIES BOther financing | Jun 2020 | $40M | $160M | Earlybird Venture Capital · IDO Investments · Longitude Capital · Wellington Partners | — |
Growth signals
Latest recorded traffic for Polares Medical is 100 monthly website visits, up 42.9% over the last three months. Polares Medical's team grew 21.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
Earlybird Venture Capital
Wellington Partners
Endeavour Vision
Decheng Capital
IDO Investments
Longitude Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Polares Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Polares Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.